These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 35908243)
21. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice. Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892 [TBL] [Abstract][Full Text] [Related]
22. Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances. McClements ME; Staurenghi F; MacLaren RE; Cehajic-Kapetanovic J Front Neurosci; 2020; 14():570909. PubMed ID: 33262683 [TBL] [Abstract][Full Text] [Related]
23. Optogenetic restoration of high sensitivity vision with bReaChES, a red-shifted channelrhodopsin. Too LK; Shen W; Protti DA; Sawatari A; A Black D; Leamey CA; Y Huang J; Lee SR; E Mathai A; Lisowski L; Y Lin J; C Gillies M; Simunovic MP Sci Rep; 2022 Nov; 12(1):19312. PubMed ID: 36369267 [TBL] [Abstract][Full Text] [Related]
24. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases. Yan B; Nirenberg S IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684 [TBL] [Abstract][Full Text] [Related]
25. Opsins for vision restoration. Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136 [TBL] [Abstract][Full Text] [Related]
26. Optogenetic approaches to vision restoration. Simunovic MP; Shen W; Lin JY; Protti DA; Lisowski L; Gillies MC Exp Eye Res; 2019 Jan; 178():15-26. PubMed ID: 30218651 [TBL] [Abstract][Full Text] [Related]
27. Optopharmacological tools for restoring visual function in degenerative retinal diseases. Tochitsky I; Kramer RH Curr Opin Neurobiol; 2015 Oct; 34():74-8. PubMed ID: 25706312 [TBL] [Abstract][Full Text] [Related]
34. A systematic comparison of optogenetic approaches to visual restoration. Gilhooley MJ; Lindner M; Palumaa T; Hughes S; Peirson SN; Hankins MW Mol Ther Methods Clin Dev; 2022 Jun; 25():111-123. PubMed ID: 35402632 [TBL] [Abstract][Full Text] [Related]
35. Towards optogenetic vision restoration with high resolution. Ferrari U; Deny S; Sengupta A; Caplette R; Trapani F; Sahel JA; Dalkara D; Picaud S; Duebel J; Marre O PLoS Comput Biol; 2020 Jul; 16(7):e1007857. PubMed ID: 32667921 [TBL] [Abstract][Full Text] [Related]
36. Strategies for expanding the operational range of channelrhodopsin in optogenetic vision. Mutter M; Münch TA PLoS One; 2013; 8(11):e81278. PubMed ID: 24312285 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms Underlying the Visual Benefit of Cell Transplantation for the Treatment of Retinal Degenerations. Léveillard T; Klipfel L Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696106 [TBL] [Abstract][Full Text] [Related]
38. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions. Ganjawala TH; Pan ZH Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746 [TBL] [Abstract][Full Text] [Related]